National COVID Vaccination Programme

A vaccination programme needs refrigerators as well as syringes. When India reached two billion COVID vaccine doses in July 2022, UNICEF’s account included a less conspicuous inventory: more than 4,195 pieces of electrical cold-chain equipment and over 600,000 cold boxes and vaccine carriers supplied to support delivery. Behind the national counter stood the equipment and workers needed to get doses to vaccination centres. [2]

The campaign had begun on 16 January 2021, initially prioritising health workers before expanding to other groups. By its first anniversary, WHO reported that 93% of adults had received a first dose and 70% had completed their primary vaccination. Those were adult coverage figures at a particular date, not percentages of every Indian, including children. [1]

Factories and a changing procurement policy

Domestic production drew on different scientific partnerships. Serum Institute of India manufactured the Oxford–AstraZeneca vaccine. Covaxin was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology in Pune. The manufacturing achievement therefore joined private industrial capacity, public research and international vaccine development; it cannot sensibly be assigned to a single institution. [3] [4]

The purchasing arrangements changed during the rollout. From May 2021, the Union government procured half the domestic vaccine supply, while states and private hospitals could purchase from the remainder. The revised guidelines issued in June acknowledged that states faced difficulties with funding, procurement and logistics, and that smaller, more remote private hospitals also faced constraints. [5]

From 21 June, the Union’s procurement share became 75%. These doses went free to states and Union Territories for free administration through government vaccination centres, with eligibility extending to all adults. Manufacturers could supply up to 25% of monthly production to private hospitals. States retained responsibility for local prioritisation and delivery. The eventual scale followed a policy revision, rather than an unchanged purchasing system. [5]

Beyond the booking screen

CoWIN supplied a digital registration and appointment system, but a person did not have to book online before receiving a dose. In June 2021, the health ministry reported that nearly 80% of doses recorded through 13 June had been administered through on-site or walk-in registration. Health workers could register people at the centre. That route mattered for people unable to navigate online booking; the figure alone cannot establish that everyone had equal access. [6]

By 17 July 2022, the cumulative tally had reached two billion doses in eighteen months. It counted injections, including repeat doses, rather than two billion different recipients. UNICEF credited health and frontline workers, scientists, manufacturers and policymakers. Its accompanying equipment inventory makes the delivery work tangible: cold rooms and refrigerators for storage, then insulated boxes and carriers for the journey onward. [2]